COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
Thales Kronenberger, Stefan Laufer, Thanigaimalai Pillaiyar
Topics & Concepts
PeptidomimeticCoronavirus disease 2019 (COVID-19)ProteaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusVirologyPandemicDrug developmentDrug discoverySmall molecule2019-20 coronavirus outbreakDrugDrug repositioningViral replicationComputational biologyAntiviral drugBiologyMedicineVirusPharmacologyBioinformaticsEnzymeInfectious disease (medical specialty)GeneticsBiochemistryDiseasePeptideOutbreakPathologySARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies